Rephonic
Artwork for The NRG Oncology Podcast

The NRG Oncology Podcast

NRG Oncology
Clinical Trials
NRG Oncology
Chemotherapy
National Cancer Institute
Immunotherapy
Radiation Therapy
Radiation Oncology
Breast Cancer
Carboplatin
Paclitaxel
Rtog-Gog 0724
Pancreatic Cancer
Proton Therapy
Lung Cancer
Endometrial Cancer
Hepatocellular Carcinoma
Pembrolizumab
Cervical Cancer
Photon Therapy
Triple Negative Breast Cancer

The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.

PublishesMonthlyEpisodes49Founded2 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for The NRG Oncology Podcast

Latest Episodes

For the 2026 Ovarian Cancer Month & Gynecologic Cancer Month, we discuss the currently enrolling NRG-GY036 clinical trial comparing 1 vs. 2 years of maintenance olaparib (with or without bevacizumab) for patients with advanced ovarian cancer with Dr.... more

YouTube

Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs. RT plus cetuximab for patients with locoregional... more

YouTube

Our co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts explore who may benefit from bladder-sparing chem... more

YouTube

For Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

QuadShot News Podcast
QuadShot News PodcastLaura, Caleb, and Sam
NEJM This Week
NEJM This WeekNEJM Group
Global News Podcast
Global News PodcastBBC World Service

Recent Guests

Lauren Mell
Principal investigator of the NRG Oncology HN016 trial, head and neck cancer expert
University of California, San Diego
Episode: NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Scott Delacroix
Urologic oncologist; medical director of urologic oncology at Mary Bird Perkins Cancer Center
Mary Bird Perkins Cancer Center
Episode: NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Himanshu Nagar
Genitourinary radiation oncology service chief at Memorial Sloan Kettering Cancer Center; new title: Manhattan Chief of Operations
Memorial Sloan Kettering Cancer Center
Episode: NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Jiayi Huang
Physician/Brain Tumor Radiotherapy Specialist
Cleveland Clinic
Episode: NRG2026 and Glioblastoma Awareness Day Special
Jay Wong
Radiation Oncologist leading CC017 discussion
Washington University in St. Louis / NRG
Episode: NRG2026 and Glioblastoma Awareness Day Special
James Abraham
Chair of Hematology and Oncology
Cleveland Clinic
Episode: NRG2026 and Glioblastoma Awareness Day Special
Anna Wilson
Gynecologic Cancer Survivor; Cancer Clinical Research Coordinator; NRG Oncology Patient Advocate
Marshfield Clinic; NRG Oncology Patient Advocate Committee
Episode: Uterine Cancer Awareness Month 2026
Amanda Fader
Professor of Gynecologic Oncology; Vice Chair of Gynecologic Surgical Operations; Director, Center for Rare Gynecologic Cancers
Johns Hopkins University
Episode: Uterine Cancer Awareness Month 2026
Carol Aghajanian
Chief of Gynecologic Medical Oncology; Chair of the NRG Gynecologic Core Committee
Memorial Sloan Kettering Cancer Center
Episode: Uterine Cancer Awareness Month 2026

Hosts

Stephen Chun
Host of The NRG Oncology Podcast; co-leader of oncology conversations; specializes in radiation oncology context and trial design within NRG.
Lauren Henke
Co-host focusing on multidisciplinary cancer care, trial design, and policy-level discussions within oncology.

Reviews

5.0 out of 5 stars from 17 ratings
  • A must listen for anyone involved in the field of radiation medicine

    Drs. Chun and Henke do a masterful job of guiding the listener through the key aspects of the discussion.

    Apple Podcasts
    5
    Frustrated with Apple TV
    United Statesa year ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

High-quality, data-driven discussions that feel accessible to practitioners seeking real-world applications.
Guests bring practical clinical and operational insights for trial execution.
Experts host conversations with depth and clarity that help listeners grasp complex trial design.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Q: What is the primary endpoint and how many patients will be enrolled in HN016?
The primary endpoint is progression-free survival, and the trial will enroll 454 patients randomized evenly between two arms in a phase 3 design.
NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Q: Can you start off telling us how cetuximab works with radiation and what the outcomes have been?
Cetuximab acts as an epidermal growth factor receptor inhibitor that sensitizes tumors to radiation, and randomized trials have shown improvements in local control and survival when added to radiation in cisplatin-ineligible patients; this helped establish cetuximab as a go-to standard in this population.
NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Q: How is adaptive radiation implemented in Gu015?
Adaptive radiation in Gu015 uses either on-table replanning or plan-of-the-day strategies to customize dose to the daily bladder size and anatomy, with real-time review by a cross-disciplinary team to ensure safety and consistency across sites.
NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Q: Who is eligible for Gu015 and what is being studied as the main outcome?
Eligible patients have non-metastatic, node-negative bladder cancer where bladder preservation is considered; the primary outcome is bladder-intact, three-year survival without progression, with secondary focus on toxicity and quality of life.
NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
Q: What is Gu015 aiming to change about current bladder cancer care?
Gu015 aims to test adaptive, shorter, five-fraction radiation schedules with the same systemic therapy used in conventional regimens, with the goal of preserving the bladder while maintaining oncologic outcomes and reducing treatment burden.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The NRG Oncology Podcast

What is The NRG Oncology Podcast about and what kind of topics does it cover?

This show centers on oncology, focusing on trial-design, translational science, and multidisciplinary patient care across a wide range of cancer types. Episodes frequently feature leaders from major cancer centers and cooperative groups discussing trial results, design rationale, regulatory and policy implications, patient advocacy, and real-world treatment trade-offs. The format blends deep clinical depth with practical insights into trial accrual, biomarker-driven strategies, and the intersection of research with health policy, making it valuable for clinicians, researchers, trial coordinators, and executives shaping cancer care. A notable strength is the density of expert guests who provide both clinical and operational perspectives, fro... more

Where can I find podcast stats for The NRG Oncology Podcast?

Rephonic provides a wide range of podcast stats for The NRG Oncology Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The NRG Oncology Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The NRG Oncology Podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for The NRG Oncology Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The NRG Oncology Podcast?

Rephonic provides comprehensive predictive audience data for The NRG Oncology Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The NRG Oncology Podcast have?

To see how many followers or subscribers The NRG Oncology Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The NRG Oncology Podcast?

These podcasts share a similar audience with The NRG Oncology Podcast:

1. QuadShot News Podcast
2. ASTRO Journals
3. NEJM This Week
4. Global News Podcast
5. Making Sense with Sam Harris

How many episodes of The NRG Oncology Podcast are there?

The NRG Oncology Podcast launched 2 years ago and published 49 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The NRG Oncology Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The NRG Oncology Podcast?

Rephonic pulls ratings and reviews for The NRG Oncology Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The NRG Oncology Podcast?

Rephonic provides full transcripts for episodes of The NRG Oncology Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The NRG Oncology Podcast?

Recent guests on The NRG Oncology Podcast include:

1. Lauren Mell
2. Scott Delacroix
3. Himanshu Nagar
4. Jiayi Huang
5. Jay Wong
6. James Abraham
7. Anna Wilson
8. Amanda Fader

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days